99

Breakthroughs
Sub Categories on Breakthroughs
Latest Articles
CRISPR treatment slows swelling in hereditary angioedema patients

CRISPR treatment slows swelling in hereditary angioedema patients

by American College of Allergy, Asthma, and ImmunologyCredit: James atmos, CC BY-SA 3.0, via Wikimedia CommonsHereditary angioedema (HAE) is a rare, genetic disorder characterized by severe

CRISPR treatment slows swelling in hereditary angioedema patients

by American College of Allergy, Asthma, and ImmunologyCredit: James atmos, CC BY-SA 3.0, via Wikimedia CommonsHereditary angioedema (HAE) is a rare, genetic disorder characterized by severe
Psilocybin found to reduce chronic pain in rats

Psilocybin found to reduce chronic pain in rats

by Bob Yirka , Medical XpressEffect of intravenous psilocybin on mechanical hypersensitivity and thermal hyperalgesia. (A) Schematic illustrating the design and timeline of the experiments. (B,C) Rats

Psilocybin found to reduce chronic pain in rats

by Bob Yirka , Medical XpressEffect of intravenous psilocybin on mechanical hypersensitivity and thermal hyperalgesia. (A) Schematic illustrating the design and timeline of the experiments. (B,C) Rats
Drugs like Ozempic won't 'cure' obesity but they might make us more fat-phobic

Drugs like Ozempic won't 'cure' obesity but they might make us more fat-phobic

by Emma Beckett,The ConversationCredit: Markus Winkler from PexelsMany havedeclareddrugs like Ozempic could "end obesity" by reducing the appetite and waistlines of million

Drugs like Ozempic won't 'cure' obesity but they might make us more fat-phobic

by Emma Beckett,The ConversationCredit: Markus Winkler from PexelsMany havedeclareddrugs like Ozempic could "end obesity" by reducing the appetite and waistlines of million
Biosimilar biologics do not always reduce out-of-pocket costs

Biosimilar biologics do not always reduce out-of-pocket costs

by Lori SolomonBiosimilar competition is not consistently associated with lower out-of-pocket (OOP) costs for commercially insured outpatients, according to a study published online March 29 inJ

Biosimilar biologics do not always reduce out-of-pocket costs

by Lori SolomonBiosimilar competition is not consistently associated with lower out-of-pocket (OOP) costs for commercially insured outpatients, according to a study published online March 29 inJ
There's only one syphilis medication for pregnant people and the supply is running out

There's only one syphilis medication for pregnant people and the supply is running out

by Alena Kuzub,Northeastern UniversityThe pharmaceutical company Pfizer is the sole manufacturer of penicillin G benzathine, the only medicine that safely treats syphilis in pregnant people. Cre

There's only one syphilis medication for pregnant people and the supply is running out

by Alena Kuzub,Northeastern UniversityThe pharmaceutical company Pfizer is the sole manufacturer of penicillin G benzathine, the only medicine that safely treats syphilis in pregnant people. Cre
Spider venom-based heart drug is a step closer

Spider venom-based heart drug is a step closer

JANUARY 17, 2024byUniversity of QueenslandPipette harvesting drop of venom from funnel web spider. Credit: University of QueenslandA spider venom molecule being investigated by a University of Q

Spider venom-based heart drug is a step closer

JANUARY 17, 2024byUniversity of QueenslandPipette harvesting drop of venom from funnel web spider. Credit: University of QueenslandA spider venom molecule being investigated by a University of Q
Knowing how clinicians make real-world decisions about drug-drug interactions can improve patient safety

Knowing how clinicians make real-world decisions about drug-drug interactions can improve patient safety

by Regenstrief InstituteDescriptive model of clinicians’ DDI decision-making process. This figure shows the coding tree developed during the inductive qualitative analysis, with primary themes sh

Knowing how clinicians make real-world decisions about drug-drug interactions can improve patient safety

by Regenstrief InstituteDescriptive model of clinicians’ DDI decision-making process. This figure shows the coding tree developed during the inductive qualitative analysis, with primary themes sh
Study discovers novel biomarker for vascular aging and neurodegeneration

Study discovers novel biomarker for vascular aging and neurodegeneration

by Melissa Rohman and Olivia Dimmer,Northwestern UniversityNotch3 deficiency results in vascular dysfunction due to impaired contractility. Immunofluorescence of phosphorylated myosin light chai

Study discovers novel biomarker for vascular aging and neurodegeneration

by Melissa Rohman and Olivia Dimmer,Northwestern UniversityNotch3 deficiency results in vascular dysfunction due to impaired contractility. Immunofluorescence of phosphorylated myosin light chai
Study finds AI can develop treatments to prevent 'superbugs'

Study finds AI can develop treatments to prevent 'superbugs'

byCleveland ClinicSchematic evolutionary simulation and tested optimization approaches. Credit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2303165121Clev

Study finds AI can develop treatments to prevent 'superbugs'

byCleveland ClinicSchematic evolutionary simulation and tested optimization approaches. Credit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2303165121Clev